MEMOTEXT is a platform for co-creation of digital patient engagement and digital therapeutics. We use health data to identify risk and drive personalization of secure, omni-channel treatment adherence, care-coordination and patient support applications.
MEMOTEXT provides secure, interactive digital engagement including SMS messaging, mobile applications, WhatsApp and voice assistants. Create your solution or choose from our marketplace of validated solutions.
Predictive and advanced analytics provide integrated insights into identification of at-risk populations and evidence-informed tailoring of communications content.
Our empathy-based and evidence-driven expertise has been shown to deliver clinical and commercial improvements in adherence, care-coordination, patient support and readmission reductions. See the outcomes and our co-commercialized marketplace.
Engagement and improvements in depresssion, psychoticism, and other symptom domains. See the A4i DTx use-case with CAMH
saved and 40,000 daily interactions freed up time for care coordinators to maintain quality of service for McKesson Canada and SE Health
Pregnant mothers on our maternal health collaboration in use by 7 public health authorities
Medication adherence improvements in a randomized control study with Johns Hopkins University
We’re a small but mighty team. We’ve crunched data, created questionnaires, integrated, tested and drank lots of coffee in the process.
Get to know the people that make up MEMOTEXT!